Posted by Pro Market
Mergers Are Bad for Innovation
By Asher Schechter
As competition authorities and economists worry about the competitive implications of increasingly concentrated markets, horizontal merger reviews should be broadened to include their potential implications for future innovation. So said Tommaso Valletti, the European Commission’s Chief Competition Economist, during a keynote lecture at an antitrust conference at Northwestern University last week.
Valletti, an Economics professor at Imperial College Business School and at the University of Rome Tor Vergata, joined the European Commission a year ago. During this time, the European Commission made a number of high-profile decisions, such as leveling a record €2.42 billion antitrust fine on Google, vetoing the proposed merger between Deutsche Boerse and the London Stock Exchange, clearing the now-completed US$130 billion merger between Dow Chemical and DuPont (now known as DowDuPont), and launching an investigation of the proposed merger between Bayer and Monsanto.
Most of Valletti’s talk during the Searle Center’s 10th Annual Conference on Antitrust Economics and Competition Policy was devoted to the subject of horizontal mergers and their impact on innovation, through the prism of the Dupont-Dow merger, which the EC cleared under the condition that DuPont divest of its global R&D pesticide facilities. It is the first to be cleared of the three mega-mergers that will reduce the number of top firms in the industry from five to three. The other two pending mergers are the Bayer’s planned purchase of Monsanto and ChemChina’s plan to buy Syngenta.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI